title: Mental status and fragile X expression in relation to FMR-1 gene mutation.
abstract: The fragile X mental retardation syndrome is caused by unstable expansion of a CGG repeat in the FMR-1 gene. Clinical expression is associated with a large expansion of the CGG repeat. The mutation in the FMR-1 gene and the cytogenetic expression of the fragile site at Xq27.3 have been studied in 52 fragile X male patients. The percentage of the cytogenetic expression of the fragile site at Xq27.3 positively correlates with the mean size of the full mutation in the FMR-1 gene (p < 0.0001) irrespective of the presence of additional premutation alleles. We noted a less frequent occurrence of additional premutation alleles in adult patients compared with juveniles, suggesting a continued mitotic instability in life. Additionally, the level of mental retardation has been ascertained in 35 patients using the Stanford-Binet or Terman-Merrill test of general intelligence. The presence of a full mutation in the FMR-1 gene seemed decisive for the occurrence of mental impairment in the patient. No correlation is observed between the degree of mental retardation and the size of the full mutation. The degree of mental retardation seemed not to be influenced by the presence of premutation alleles in part of the cells in addition to a full mutation. One patient is described with the 'Prader-Willi-like' subphenotype of the fragile X syndrome, showing a deletion in the FMR-1 gene in a part of his cells in addition to a full mutation.
authors.affiliation: Department of Clinical Genetics, University Hospital Dijkzigt, Erasmus University, Rotterdam, The Netherlands.
authors.forename: B B
authors.initials: BB
authors.lastname: de Vries
authors.forename: A M
authors.initials: AM
authors.lastname: Wiegers
authors.forename: E
authors.initials: E
authors.lastname: de Graaff
authors.forename: A J
authors.initials: AJ
authors.lastname: Verkerk
authors.forename: J O
authors.initials: JO
authors.lastname: Van Hemel
authors.forename: D J
authors.initials: DJ
authors.lastname: Halley
authors.forename: J P
authors.initials: JP
authors.lastname: Fryns
authors.forename: L M
authors.initials: LM
authors.lastname: Curfs
authors.forename: M F
authors.initials: MF
authors.lastname: Niermeijer
authors.forename: B A
authors.initials: BA
authors.lastname: Oostra
mesh_terms: D000328:Adult; D001483:Base Sequence; D002648:Child; D004252:DNA Mutational Analysis; D005500:Follow-Up Studies; D051860:Fragile X Messenger Ribonucleoprotein 1; D005600:Fragile X Syndrome / Q000235:genetics* / Q000523:psychology*; D015870:Gene Expression; D005796:Genes; D006801:Humans; D008607:Intellectual Disability / Q000235:genetics* / Q000523:psychology; D007361:Intelligence Tests; D008297:Male; D008969:Molecular Sequence Data; D009154:Mutation; D009419:Nerve Tissue Proteins / Q000096:biosynthesis / Q000235:genetics*; D016601:RNA-Binding Proteins; D012091:Repetitive Sequences, Nucleic Acid
chemical_list: D051860:Fragile X Messenger Ribonucleoprotein 1; D009419:Nerve Tissue Proteins; D016601:RNA-Binding Proteins; C497683:FMR1 protein, human